Alaunos is a clinical stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. With their robust and innovative discovery engine, they strike cancer at its core by engineering cell therapies that target neoantigens arising from genomic mutations. They have developed proprietary, rapid, cost-effective solutions to deliver tumor-specific…More killer T cells to large cancer patient populations with unmet clinical need. They are based in Houston, TX, home to the largest medical center in the world; and in a state with no state income tax and a low cost of living.
Social Media Links
REPORT RATINGS
4.8 / 5.0 (177)
Alaunos Therapeutic reports have an aggregate usefulness score of 4.8 based on 177 reviews.